Biology of Autism — Molecular Pathways Map

Founding Conditions

Immune Activation & IDO1

Astrocyte / Glial Layer

Synapse Architecture

ASD Features

SST-14 / Neuropeptide Pathway

Self-Sustaining Loop

Founding
Conditions

Prenatal / Perinatal

L1 — Reduced Acid-Production Capacity

Prenatal hormonal/immune disruption impairs parietal cell development. C-section bypasses microbial seeding; hospital strep colonises and blocks CD26. Formula feeding loses oligosaccharides, colostrum, and motilin activation. Pre-conception OCP use depletes zinc — the cofactor for carbonic anhydrase, which generates the H⁺ for HCl production. Folate receptor antibodies and MTHFR C677T compound methylation vulnerability from birth.

Reduced parietal cell HCl → gastric pH elevated from birth

Environmental / Toxic

L1 — Ongoing pH & CD26 Disruption

Glyphosate depletes acid-producing commensals while sparing LPS-producing species. Mercury binds the CD26 receptor site directly, blocking adenosine deaminase. Organophosphates downregulate muscarinic receptors, paradoxically reducing parietal cell responsiveness. Viral proteins (pertussis toxin, CMV, EBV) independently impair adenylyl cyclase signalling.

Glyphosate + mercury + organophosphates → pH ↑ and CD26 blockade

Ongoing Drivers

L1 — What Perpetuates pH Dysregulation

H. pylori alkalinises the stomach via urease. Recurrent strep reintroduces streptokinase, compounding CD26 blockade with each episode. Chronic sympathetic dominance reduces vagal acid stimulation. Acetaminophen depletes glutathione. PPI therapy — often prescribed for reflux that reflects low motility, not acid excess — deepens the underlying dysregulation while relieving the surface symptom.

H. pylori + strep + PPI therapy → self-perpetuating pH elevation

Constitutional Susceptibility

L1 — Why the Same Conditions Produce Different Outcomes

The founding conditions above are common; most exposed children do not develop the cascade. Seven tipping points — gastric acid capacity, CD26/DPP-IV efficiency, methylation reserve, inflammatory resolution (ALOX/SPM), kynurenine pathway bias (KMO), mitochondrial buffering, and HLA-mediated autoantibody susceptibility — determine how much environmental load a given child can absorb before each step fails.

Same founding conditions, different constitutional profile, different outcome

elevated gastric pH → pepsin inactivation → two parallel arms

Pepsin
Failure

Convergent Mechanism 1 — Upstream of Everything

L2 — Pepsin Inactivation & Hidden Malnutrition

Pepsin requires pH ≈2.0 and is essentially inactive above pH 4.0. Elevated gastric pH prevents pepsin from cleaving the proline bonds in casein/gluten. Three amino acids depend critically on this cleavage — phenylalanine, tyrosine, and tryptophan. No amount of dietary protein corrects the resulting deficiency: a child eating an apparently adequate diet is biochemically deficient in the precursors for dopamine, serotonin, and melatonin. Intact peptide fragments also penetrate the mucosal wall, opening the gut barrier.

pH > 4.0 → pepsin inactive → Phe/Tyr/Trp deficiency + gut permeability ↑

Arm A — Gut SST-28 Overactivation

L2 — Opioid Peptides → CCK → SST-28 ↑

Casomorphin and gliadorphin (exorphins from incomplete digestion) bind mu-opioid receptors, driving chronic CCK overactivation. Unlike normal episodic CCK cycling, this stimulus never switches off. Chronic CCK drives gut SST-28 into sustained overexpression, tonically suppressing gastric acid, secretin, VIP, and motilin release — deepening the pH dysregulation that started the cascade.

Opioid peptides → CCK ↑ → gut SST-28 ↑ → digestive hormone cascade suppressed

Arm B — CD26 Blockade & Methylation Failure

L2 — Adenosine Accumulation → Methionine Synthase Inhibition

The same opioid peptides — plus streptokinase, mercury, and constitutive CD26/DPP-IV inefficiency — block the adenosine deaminase docking site on CD26. Adenosine accumulates and directly rate-limits methionine synthase, stalling the methylation cycle: neurotransmitter synthesis, immune cell switching, DNA methylation, and cellular energy production fail simultaneously. Elevated homocysteine is the clinical fingerprint.

CD26 blocked → adenosine ↑ → methionine synthase ↓ → SAMe ↓ → homocysteine ↑

gut barrier compromised → LPS translocation → systemic immune activation

Immune
Activation

Convergent Mechanism 3

LPS Translocation & Systemic Immune Activation

Proline-bonded peptides penetrating the mucosal wall open a conduit for bacterial lipopolysaccharide (LPS) into systemic circulation. At nanogram concentrations LPS activates macrophages and microglia, producing IL-1β, IL-6, TNF-α, and IFN-γ. Activated microglia release IL-1α, TNF-α, and complement C1q — the three signals driving A1 astrocyte polarisation downstream.

LPS → macrophage/microglial activation → IL-1β, IL-6, TNF-α, IFN-γ ↑

Convergent Mechanism 4A — Excitotoxic Arm

IDO1 Activation & the Kynurenine Pathway

Sustained cytokine elevation activates IDO1, diverting tryptophan toward kynurenine — the K:T ratio is the direct quantitative measure of this diversion. The pathway bifurcates toward quinolinic acid (QUIN), a potent NMDA receptor agonist. QUIN forces calcium into SST-14 interneurons faster than mitochondria can buffer it — these cells fire tonically at high frequency and are disproportionately vulnerable. Downstream NAD⁺ consumption under chronic IDO1 activation compounds the energy deficit.

Cytokines → IDO1 ↑ → K:T ratio ↑ → QUIN ↑ → NMDA/calcium overload in SST-14 cells

excitotoxic arm + transcriptional arm converge on the same interneuron

Convergent
Node

Four Simultaneous Suppression Mechanisms

SST-14 Interneuron Silencing

The IDO1-kynurenine excitotoxic arm and the NF-κB-CREB transcriptional arm arrive at the same cellular target simultaneously, alongside adenosine-mediated cAMP suppression and autoantibody-mediated receptor jamming. SST-14 interneurons — which coordinate oxytocin, VIP, and secretin release — are suppressed at four independent levels at once, making this the single convergent node through which diverse upstream insults produce the same downstream outcome.

Metabolic depletion + transcriptional suppression + cAMP starvation + autoantibody jamming → SST-14 silenced

Four
Mechanisms

Mechanism A — Transcriptional

NF-κB Hijacks the Transcriptional Machinery

NF-κB competes directly with CREB for CBP (the shared co-activator) and recruits HDAC enzymes to compact the chromatin at the SST-14 gene's cAMP response element (CRE). The gene is intact; the machinery that activates it has been captured. This is the mechanism immunoglobulin therapy relieves most directly — the basis for State 1 recovery.

NF-κB ↑ → CBP competition + HDAC recruitment → SST-14 CRE inaccessible

Mechanism B — cAMP Starvation

Adenosine-Gαi Suppression of Adenylyl Cyclase

Adenosine accumulated via CD26 blockade (Arm B) activates inhibitory Gαi-coupled receptors on SST-14 interneurons, suppressing adenylyl cyclase independently of Mechanism A. A second, independent Gαi input runs through mu-opioid receptors activated by casomorphin/gliadorphin directly. Less cAMP means CREB is never phosphorylated even where NF-κB pressure is low. The estrogen-cAMP axis (Gq-mER) partially bypasses this route in females — the leading explanation for the 4:1 male-to-female ratio.

Adenosine + opioid peptides → Gαi ↑ → AC ↓ → cAMP ↓ → CREB not phosphorylated

Mechanism C — Metabolic (State 2)

Excitotoxic Calcium Overload & NAD⁺ Depletion

Even where transcriptional suppression is relieved, an interneuron in State 2 cannot resume tonic firing without metabolic substrate restoration — the biomarker distinction (elevated lactate:pyruvate) that determines whether immune clearance alone is sufficient or whether mitochondrial/MSC support is also required.

QUIN/NMDA calcium overload + NAD⁺ depletion → mitochondrial exhaustion

Mechanism D — Autoantibodies (State 3 driver)

Surface Receptor Jamming

The chronically activated adaptive immune system produces autoantibodies against neural surface proteins on SST-14 interneurons, impairing membrane signal transduction independently of transcriptional suppression — and, in sustained cases, contributing to the partial structural loss defining State 3.

Autoantibodies → SST-14 surface receptors jammed → functional silencing

SST-14 loss removes its own anti-inflammatory tone → microglial M1 → IL-1β + TNF-α + C1q → astrocyte A1 conversion

Glial
Layer

M1 Microglia

L6A — Microglial Pro-Inflammatory Shift

NF-κB-driven cytokines push microglia from homeostatic to M1 states. Activated M1 microglia release the IL-1β + TNF-α + C1q triad — the precise signal that converts astrocytes to A1 reactive phenotype. Also directly prune synapses via complement-mediated engulfment.

NF-κB → M1 microglia → IL-1β + TNF-α + C1q ↑

A1 Reactive Astrocytes

L6B — Astrocyte Phenotype Shift

The IL-1β + TNF-α + C1q triad from M1 microglia converts astrocytes from their normal supportive (A2) state to A1 reactive state. A1 astrocytes are characterized by elevated GFAP, S100β, complement C3, and a complete reversal of their synaptogenic protein profile.

IL-1β + TNF-α + C1q → A1 astrocytes → GFAP ↑ C3 ↑

A1 astrocytes invert synaptogenic protein balance

Synapse
Proteins

Hevin (SPARCL1) ↓ Suppressed

L7A — Synapse Builder Silenced

Hevin bridges Neurexin-1α to Neuroligin-1, initiating thalamocortical synapse assembly. In A1 astrocytes, hevin production falls. SPARCL1 mutations associated with ASD risk reduce hevin secretion and trigger ER stress. Fewer synapses form in sensory integration and social processing circuits.

Neurexin-1α ←[Hevin]→ Neuroligin-1 ✗ blocked

SPARC ↑ Over-Expressed

L7B — Pruning Signal Pathological

SPARC binds hevin and physically blocks the Neurexin-Neuroligin bridge. In A1 astrocytes, SPARC is massively over-expressed — triggered by TNF-α, IL-1β, and microglial activation. Elevated SPARC removes synapses that developmental circuits required. SPARC as DAMP: Secreted SPARC also acts as a damage-associated molecular pattern (DAMP), activating TLR4 on microglia and feeding back into NF-κB — creating a direct synapse-to-inflammation feedforward loop.

SPARC ↑ → blocks Hevin bridge → synapse elimination ↑

Glypicans 4/6 ↓ Irregular

L7C — Synapse Maturers Impaired

Glypicans recruit AMPA receptors (GluA1) to postsynaptic sites, converting silent synapses into functional ones. In A1 astrocytes, glypican secretion becomes irregular. Existing circuits remain structurally present but functionally silent — incapable of efficient signal transmission.

Glypican 4/6 ↓ → AMPA ↓ → silent synapses persist

hevin ↓ + SPARC ↑ + glypicans ↓ → aberrant synaptic architecture

Neural
Architecture

Thalamocortical Circuit

L7D — Under-Connected Sensory Relay

Hevin is most critical for thalamocortical synapse formation. Reduced hevin → fewer, weaker connections between thalamic sensory relay nuclei and cortical processing regions → sensory information arrives at the cortex unfiltered and poorly integrated.

Thalamus ⟷ Cortex: hevin-dependent synapses ↓

Connectivity Signature

L7E — Hyper-Local + Reduced Long-Range Connectivity

The hevin/SPARC imbalance produces the connectivity pattern consistently documented in autism neuroimaging: dense local connectivity within cortical regions, with reduced long-range integration across brain networks. Both over- and under-connectivity are present simultaneously — in different circuits.

Local connectivity ↑ | Long-range integration ↓

aberrant connectivity + SST-14 output below threshold → coordinating signal lost across three neuropeptide systems

Neuro-
peptide
Cascade

Oxytocin

Loss of Coordinated Social Salience Signaling

SST-14 interneurons in the PVN modulate oxytocin timing and amplitude. Loss produces blunted, uncoupled release — a motivational deficit, not a structural one. Explains the SOARS-B trial's definitive null result for exogenous oxytocin: the circuit timing SST-14 provides cannot be replaced downstream.

SST-14 ↓ → oxytocin release blunted/uncoupled → social motivation ↓

VIP

G-Protein Cascade Failure Across Four Systems

VIP's receptor → Gαs → AC → cAMP → PKA → CREB chain is disrupted at three independent points (adenosine-Gαi, lost SST-14 coordination, NF-κB/CREB suppression) — producing circadian disruption, sensory gating failure, gut dysmotility, and loss of immune anti-inflammatory tone simultaneously.

VIP cascade disrupted → sleep + sensory + gut + immune, one mechanism

Secretin

Compound Failure From Above and Below

Gut pH dysregulation prevents the pH 4.2 threshold for S-cell release (from below); SST-14 silencing removes central gut-brain coordination (from above). The Horvath 1998 case series succeeded because IV delivery bypassed the blocked release mechanism entirely — later unselected RCTs failed by diluting the responsive subgroup.

Gut SST-28 ↑ + SST-14 ↓ → secretin signalling fails from two directions

coordinated neuropeptide loss → observable phenotype cluster

ASD
Features

Sensory

L8A — Sensory Over-Reactivity

Unfiltered thalamocortical input → sensory information not gated or integrated before reaching conscious awareness → sensory over-responsivity to sound, touch, light, texture. Common in 80%+ of autistic individuals.

Social

L8B — Social Cognition Difficulty

Two distinct biological roots. Root 1 (cortical): complex social understanding requires long-range integration across medial prefrontal cortex, superior temporal sulcus, and amygdala — reduced long-range connectivity impairs theory of mind, pragmatic language, and social reciprocity. Root 2 (hypothalamic): IDO1-driven serotonin depletion suppresses 5-HT2-mediated PVN activation, reducing oxytocin release — diminishing social motivation and the reward valence of social engagement at the neurochemical level. Both roots can be active simultaneously; addressing only one produces only partial social gains.

Cognitive

L8C — Rigidity + Perseveration

CREB/BDNF impairment (via SST-14 silencing) + silent synapses (via glypican deficit) → circuits fail to update through experience → cognitive rigidity, difficulty with transitions, restricted interests, perseverative patterns.

L8D — GI Disruption

Gut dysbiosis (upstream trigger) + serotonin depletion (kynurenine pathway) + vagal nerve inflammatory signaling → dysmotility, constipation, pain, leaky gut. GI symptoms and autistic traits share a common upstream origin — the inflammatory cascade.

Sleep + Mood

L8E — Sleep Dysregulation + Mood Instability

Serotonin depletion (kynurenine pathway) → impaired melatonin synthesis → circadian dysregulation. HPA axis dysregulation (cortisol blunting) → emotional dysregulation, anxiety, low frustration tolerance.

Motor / Balance

L8F — Motor Coordination + Balance Difficulties

CREB/BDNF impairment reduces cerebellar circuit refinement — the cerebellum is highly dependent on activity-dependent synaptic consolidation for motor learning and balance calibration. Mitochondrial dysfunction limits ATP availability in motor neurons. Hevin deficit reduces thalamocortical relay precision affecting motor planning circuits. Manifests as dyspraxia, gait irregularities, poor fine motor control, and balance difficulties — frequently reported but often overlooked as core cascade outputs.

Theoretical framework — not clinical guidance. The Autism Spectrum Disorder (ASD) Cascade is a systems-biology model integrating peer-reviewed findings across immunology, metabolism, gut biology, and neuroscience into a proposed mechanistic map. Individual components are supported by published research; the full integrated cascade has not been validated as a unified model in large clinical trials. It is intended as a research-informed framework — not a diagnostic tool or treatment protocol. All intervention decisions require qualified clinical oversight. For the evidence base, see the ASD Cascade Citations document in this suite.